Important Announcement: AmplifyBio Operations Closure
It is with deep sadness and gratitude that we announce the closure of AmplifyBio’s operations. This decision comes after months of tireless efforts by the AmplifyBio leadership team, investors and other key stakeholders to explore and exhaust all investment and acquisition possibilities. Like any startup, AmplifyBio's growth strategy relied on meeting revenue targets and a supportive investor climate. At the time AmplifyBio launched, market conditions were favorable for early phase drug development. That market sector has experienced a significant shift over the last couple of years leading to a scarcity of investor financing for early-stage biotech companies, which greatly impacted the ability to grow. |
Recent News